The Filing Desk

Ardelyx vs Innoviva

Ardelyx ARDX · Innoviva INVA · Pharmaceuticals

Innoviva reported revenue of $411 million in fiscal 2025, about the same as Ardelyx's $407 million in fiscal 2025. Ardelyx's revenue grew 22.1% in its latest year, and Innoviva's grew 14.7%. Ardelyx had an operating margin of -10.1%, against 39.8% at Innoviva. Free cash flow was −$44 million at Ardelyx and $196 million at Innoviva.

Side by side

ArdelyxInnoviva
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$407M$411M
Revenue growth22.1%14.7%
Revenue growth a year, last 5 years121.7%4.1%
Gross margin90.3%74.8%
Operating margin−10.1%39.8%
Net margin−15.1%65.9%
Free cash flow−$44M$196M
Free cash flow margin−10.8%47.6%
Return on capital−36.1%17.9%
Net debt to EBITDA——
Dividends and buybacks$0M$4M
Change in diluted share count2.5%14.2%
Last close$3.09$19.03
P/E at the last close—9.5×
Insider trades, last 12 months——
Piotroski F-score2 of 96 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
ArdelyxInnoviva
Operating margin
Percent of revenue
ArdelyxInnoviva
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
ArdelyxInnoviva

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Ardelyx and Innoviva pages.